Indonesia and Tanzania Launch TB Nutrition Trial
The PHOTON study evaluates if nutritional supplementation improves tuberculosis prevention and treatment outcomes.
Updated on Oct. 22, 2026 in Nutrition
Live Poll
Do you believe nutritional therapy should be a standard component of medical treatment plans?
Researchers in Indonesia and Tanzania are launching the five-year PHOTON clinical trial to test the effectiveness of nutritional support in treating tuberculosis. The study provides participants with micronutrient and balanced protein supplementation to determine if it outperforms standard medical treatment alone.
Why it matters
Tuberculosis treatment success is closely tied to a patient's nutritional status and socio-economic conditions. By integrating nutritional interventions, researchers hope to improve outcomes for those affected by the disease.
The PHOTON study tracks the effects of six months of micronutrient and balanced protein supplementation over a five-year period. This research follows the RATIONS study in India, which reported a 48 percent reduction in tuberculosis incidence using nutritional support.
The players
University of Indonesia
This educational and research institution is a primary site for conducting clinical trials related to public health interventions.
Gates Foundation
This organization funds global health initiatives and research projects aimed at reducing disease burden in developing nations.
Wellcome Trust
This global charitable foundation supports science and research to improve human health and address pressing medical challenges.
Novo Nordisk
This multinational pharmaceutical company provides support for medical research and international health programs.
The details
The research, supported by the Gates Foundation, Wellcome Trust, and Novo Nordisk, operates at the University of Indonesia and in Tanzania. Investigators are combining the intervention with broader health efforts, such as the Free Health Check program and household contact screening.
Timeline
Indonesia identified 867,000 tuberculosis cases during 2025.
Detection efforts improved in 2026 through integrated screening programs.
The Deputy Health Minister formally announced the PHOTON study on October 22, 2026.
The Big Picture
The PHOTON study follows the research patterns established by the RATIONS study, which proved the efficacy of nutritional interventions for tuberculosis patients. This trial marks a shift toward combining standardized medical care with nutritional therapy to combat the disease.
Participants in the trial will receive balanced protein and micronutrient supplementation alongside their standard medical treatment. This study provides vital data on how dietary adjustments could eventually be integrated into routine tuberculosis care protocols worldwide.
The takeaway
The PHOTON study represents a shift in tuberculosis treatment by focusing on the link between malnutrition and disease recovery. Integrating nutrition into healthcare routines may offer a more comprehensive approach to managing global tuberculosis outbreaks.
Further reading
Learn more about the latest research in this field at the /health/nutrition/ section.
Source note: This article includes information reported by Antara News.
Live Poll
Do you believe nutritional therapy should be a standard component of medical treatment plans?
